USA - NASDAQ:WALD - JE00BPG99318 - Common Stock
The current stock price of WALD is 1.89 USD. In the past year, price decreased by -41.3%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| KVUE | KENVUE INC | 15.57 | 31.97B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 52.49 | 31.78B | ||
| ELF | ELF BEAUTY INC | 23.79 | 4.17B | ||
| BRBR | BELLRING BRANDS INC | 12.42 | 3.40B | ||
| COTY | COTY INC-CL A | 18.42 | 3.06B | ||
| IPAR | INTERPARFUMS INC | 16.69 | 2.81B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 7.14 | 842.32M | ||
| OLPX | OLAPLEX HOLDINGS INC | 12.75 | 680.42M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 6.97 | 476.19M | ||
| NATR | NATURES SUNSHINE PRODS INC | 22.52 | 373.44M | ||
| USNA | USANA HEALTH SCIENCES INC | 9.79 | 350.60M | ||
| HNST | HONEST CO INC/THE | 43 | 287.08M |
Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. The company is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.
WALDENCAST PLC-A
Michelin House, 81 Fulham Road
London NEW YORK GB
CEO: Michel Brousset
Employees: 335
Phone: 442031960264
Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. The company is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.
The current stock price of WALD is 1.89 USD.
WALD does not pay a dividend.
WALD has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
WALDENCAST PLC-A (WALD) operates in the Consumer Staples sector and the Personal Care Products industry.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on WALD.
You can find the ownership structure of WALDENCAST PLC-A (WALD) on the Ownership tab.
ChartMill assigns a technical rating of 1 / 10 to WALD. When comparing the yearly performance of all stocks, WALD is a bad performer in the overall market: 82.72% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to WALD. WALD may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months WALD reported a non-GAAP Earnings per Share(EPS) of -0.39. The EPS increased by 60.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.35% | ||
| ROE | -6.41% | ||
| Debt/Equity | 0.21 |
12 analysts have analysed WALD and the average price target is 3.57 USD. This implies a price increase of 88.89% is expected in the next year compared to the current price of 1.89.
For the next year, analysts expect an EPS growth of -73.27% and a revenue growth 8.78% for WALD